Ventyx Biosciences, Inc. announced the resignation of Christopher Krueger as Chief Business Officer of the Company, effective on April 15, 2024, to pursue other opportunities. Mr. Krueger?s resignation is voluntary and for personal reasons and is not the result of any disagreement with the Company related to its operations, policies, or practices. The Company thanks Mr. Krueger for his contributions to the Company.